Bringing Medicines for HIV Prevention to a Family Planning Clinic

Conditions

• HIV
• PrEP

Eligibility Criteria

Sex

ALL

Age

16 Years - N/A

Healthy Volunteers

Accepted

Interventions

• Patient participant screening — BEHAVIORAL
  Patient participants will be provided with the standardized PrEP screening and initiation protocol.
• Physician participant training — BEHAVIORAL
  Physician participants will be trained in the investigators' standardized PrEP screening and initiation protocol.

Study Details

The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are: 1. Do patients find it acceptable to be asked about, and offered, PrEP during their visit to a family planning clinic? 2. What things make it easier or harder to ask about PrEP in a family planning clinic setting? 3. What things make it easier or harder to begin PrEP in a family planning clinic setting? Patient participants: 1. Will receive standardized counseling about PrEP. 2. Will have the opportunity to begin PrEP as part of their routine, ongoing care. 3. Will be asked to complete a survey about their experiences. Physician participants: 1. Will receive standardized education about PrEP. 2. Will talk to patient participants about PrEP, and support patient participants who want to begin PrEP. 3. Will be asked to complete pre-and post-study surveys about their experiences. 4. May be asked to complete a post-study in-depth interview about their experiences.

Key Dates

Start date

May 28, 2026

Status verified

May 2026

Primary completion

Jul 31, 2026

Completion

Jul 31, 2026

Study Design

Enrollment

83 participants (estimated)

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SCREENING

Arms

• Experimental: Patient Participant
• Experimental: Physician Participant

Primary Outcome Measure

Acceptability of Intervention Measure [ Time Frame: Up to hour 6 for patient participants; Up to month 12 for physician participants ]

Central Contacts

• Benjamin P Brown, MD, MS
  401-274-1122
  [email protected]
• Erica J Hardy, MD, MMSc, MA
  401-453-7950
  [email protected]

Locations (1)

Find similar trials in Providence, RI

Related Studies

• Health Effects of the Standardized Research E-Cigarette in Smokers With HIV Smokers With HIV
  Recruiting · Brown University · Providence, Rhode Island
• Optimization of a Behavioral Intervention to Increase Physical Activity in Older Adults Living With HIV
  Recruiting · Butler Hospital · Minneapolis, Minnesota
• Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
  Recruiting · Westat · Los Angeles, California
• Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
  Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Washington D.C., District of Columbia